Q2 2026 13F filing
Updated 27 days ago156 disclosed positions worth $928.2M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S STT-PG SPDR SERIES TRUST | $47.5M | 300.0K | 5.11% | — |
| 2 | A AAVXF ABIVAX SA | $45.5M | 341.1K | 4.90% | — |
| 3 | A AAVXF ABIVAX SA | $43.4M | 328.6K | 4.67% | — |
| 4 | K KOD KODIAK SCIENCES INC | $41.3M | 1.06M | 4.45% | — |
| 5 | A AAVXF ABIVAX SA | $33.3M | 250.0K | 3.59% | — |
| 6 | I IONS IONIS PHARMACEUTICALS INC | $31.7M | 400.0K | 3.42% | — |
| 7 | M MRNA MODERNA INC | $28M | 400.0K | 3.02% | — |
| 8 | A ALMS ALUMIS INC | $24.5M | 870.5K | 2.64% | — |
| 9 | P PRAX PRAXIS PRECISION MEDICINES I | $24.4M | 72.8K | 2.63% | — |
| 10 | I IONS IONIS PHARMACEUTICALS INC | $23.8M | 300.0K | 2.56% | — |
| 11 | P PCVX VAXCYTE INC | $22.6M | 388.7K | 2.43% | — |
| 12 | A ANIP ANI PHARMACEUTICALS INC | $22.5M | 272.1K | 2.43% | — |
| 13 | C CLDX CELLDEX THERAPEUTICS INC NEW | $17.8M | 478.5K | 1.92% | — |
| 14 | R RCUS ARCUS BIOSCIENCES INC | $15.6M | 504.6K | 1.68% | — |
| 15 | R RLMD RELMADA THERAPEUTICS INC | $14.9M | 2.15M | 1.60% | — |
| 16 | C CAPR CAPRICOR THERAPEUTICS INC | $14.5M | 604.2K | 1.57% | — |
| 17 | C COGT COGENT BIOSCIENCES INC | $14.3M | 370.1K | 1.54% | — |
| 18 | ? N/A NEWAMSTERDAM PHARMA COMPANY | $13.6M | 400.0K | 1.46% | — |
| 19 | V VERA VERA THERAPEUTICS INC | $13.3M | 310.0K | 1.43% | — |
| 20 | C CTNM CONTINEUM THERAPEUTICS INC | $13.2M | 807.9K | 1.43% | — |
| 21 | ? N/A TENAX THERAPEUTICS INC | $11.5M | 787.6K | 1.23% | — |
| 22 | B BEPC C4 THERAPEUTICS INC | $11.4M | 2.43M | 1.22% | — |
| 23 | M MAZE MAZE THERAPEUTICS INC | $11.3M | 379.0K | 1.22% | — |
| 24 | B BHVN BIOHAVEN LTD | $11.1M | 748.2K | 1.20% | — |
| 25 | C CNTB CONNECT BIOPHARMA HLDGS LTD | $10.8M | 4.54M | 1.16% | — |
| 26 | A ANRO ALTO NEUROSCIENCE INC | $10.7M | 407.3K | 1.16% | — |
| 27 | P PHVS PHARVARIS N V | $10.7M | 308.9K | 1.15% | — |
| 28 | A ALMS ALUMIS INC | $10M | 356.3K | 1.08% | — |
| 29 | J JBIO JADE BIOSCIENCES INC | $9.5M | 427.3K | 1.02% | — |
| 30 | ? N/A DAMORA THERAPEUTICS INC | $8.7M | 335.7K | 0.94% | — |
| 31 | K KOD KODIAK SCIENCES INC | $8.5M | 217.7K | 0.91% | — |
| 32 | C CAPR CAPRICOR THERAPEUTICS INC | $8.4M | 350.0K | 0.91% | — |
| 33 | A ARWR ARROWHEAD PHARMACEUTICALS IN | $8.2M | 100.0K | 0.88% | — |
| 34 | V VRDN VIRIDIAN THERAPEUTICS INC | $7.8M | 425.0K | 0.84% | — |
| 35 | P PTHS PELTHOS THERAPEUTICS INC | $7.3M | 256.6K | 0.78% | — |
| 36 | Z ZURA ZURA BIO LTD | $7.2M | 1.22M | 0.77% | — |
| 37 | T TECX TECTONIC THERAPEUTIC INC | $7.1M | 205.8K | 0.76% | — |
| 38 | P PRAX PRAXIS PRECISION MEDICINES I | $6.7M | 20.0K | 0.72% | — |
| 39 | S SPRB SPRUCE BIOSCIENCES INC | $6.6M | 121.4K | 0.71% | — |
| 40 | H HIMS HIMS & HERS HEALTH INC | $6.5M | 188.4K | 0.70% | — |
| 41 | E ELVN ENLIVEN THERAPEUTICS INC | $6.4M | 126.5K | 0.69% | — |
| 42 | P PRQR PROQR THRAPEUTICS N V | $6.4M | 3.43M | 0.69% | — |
| 43 | D DRUG BRIGHT MINDS BIOSCIENCES INC | $6.2M | 89.0K | 0.67% | — |
| 44 | O OVID OVID THERAPEUTICS INC | $6.1M | 2.27M | 0.66% | — |
| 45 | ? N/A OCUGEN INC | $6.1M | 3.96M | 0.65% | — |
| 46 | A ACOG ALPHA COGNITION INC | $6M | 836.3K | 0.65% | — |
| 47 | K KYMR KYMERA THERAPEUTICS INC | $5.8M | 50.4K | 0.62% | — |
| 48 | H HROW HARROW INC | $5.8M | 135.8K | 0.62% | — |
| 49 | K KZIA KAZIA THERAPEUTICS LTD | $5.6M | 396.2K | 0.60% | — |
| 50 | R RARE ULTRAGENYX PHARMACEUTICAL IN | $5.5M | 165.6K | 0.60% | — |